This episode of Lung Cancer Considered focuses on an EGFR mutant non-small cell lung cancer virtual tumor board case that involves a 41-year-old woman who is a never smoker and presents with a dry cough, chest pain, and weight loss.  Discussing treatment options on this podcast with host Dr. Narjust Duma are Dr. Alfredo Addeo, senior oncologist at Geneva Hospital in Geneva, Switzerland, and Dr. Helena Yu, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.

This episode of Lung Cancer Considered focuses on an EGFR mutant non-small cell lung cancer virtual tumor board case that involves a 41-year-old woman who is a never smoker and presents with a dry cough, chest pain, and weight loss. Discussing treatment options on this podcast with host Dr. Narjust Duma are Dr. Alfredo Addeo, senior oncologist at Geneva Hospital in Geneva, Switzerland, and Dr. Helena Yu, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.

Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Science

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Share Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo

Sign up to save your podcasts

Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo

Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo

More shows like Lung Cancer Considered

Freakonomics Radio

NEJM This Week

JAMA Clinical Reviews

Hidden Brain

The NPR Politics Podcast

ASCO Daily News

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The Peter Attia Drive

Harrison's PodClass: Internal Medicine Cases and Board Prep

The Curious Clinicians

People I (Mostly) Admire

Conversations in Lung Cancer Research

The Weekly Show with Jon Stewart

Two Onc Docs